The transformation and innovation development of biopharmaceutical industry under the background of aging

被引：0

作者：

Feng, Jiao ^{[1
]}

Zhu, Yan ^{[1
]}

Zhang, Jie ^{[1
]}

机构：

[1] Liaoning Econ Management Cadre Inst, Biol Engn Dept, Shenyang 110122, Liaoning, Peoples R China

来源：

PROCEEDINGS OF THE 2017 2ND INTERNATIONAL CONFERENCE ON FINANCIAL INNOVATION AND ECONOMIC DEVELOPMENT (ICFIED 2017) | 2017年 / 34卷

关键词：

Aging; biopharmaceutical industry; strategic emerging industries; innovation development; transformation;

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

With the acceleration of population aging process, the elderly industry has been paid more attention. It will effectively promote transformation and innovation development of the third industry, especially the biopharmaceutical industry. From now to 2030, the aging will develop rapidly. The change of population aging would be adapted only by speeding up the transformation of economic structure and the construction of the pharmaceutical industry. Consequently, biopharmaceutical industry, which is one of the strategic emerging industries should find a new way to adapt to its new opportunities and challenges. In this study, the strategic position, emphasis and difficulty of transformation and innovation development of biopharmaceutical industry under the background of the rapid aging was summarized and a feasible strategy measure was proposed.

引用

下载

页码：42 / 45

页数：4

共 50 条

[21] Network embeddedness and new product development in the biopharmaceutical industry: The moderating role of open innovation flow
Mazzola, Erica
Perrone, Giovanni
Kamuriwo, Dzidziso Samuel
INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS, 2015, 160 : 106 - 119
[22] University-industry collaboration and firm innovation: an empirical study of the biopharmaceutical industry
Tian, Mingyu
Su, Yiwei
Yang, Zhong
JOURNAL OF TECHNOLOGY TRANSFER, 2022, 47 (05): : 1488 - 1505
[23] Study of the College Development Strategy under the Background of System Innovation
Fan Ruyong
CALL OF PAPER PROCEEDINGS OF 2008 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND ENGINEERING, 2008, : 540 - 544
[24] Business model innovation opportunities for the biopharmaceutical industry: A systematic review
Downs J.B.
Velamuri V.K.
Downs, James B. (james.downs@hhl.de), 1600, ThinkBiotech LLC (22): : 19 - 63
[25] MULTISCALAR CLUSTERS AND NETWORKS AS THE FOUNDATIONS OF INNOVATION DYNAMICS IN THE BIOPHARMACEUTICAL INDUSTRY
Depret, Marc-Hubert
Hamdouch, Abdelillah
REGION ET DEVELOPPEMENT, 2011, (33): : 227 - 268
[26] Integrating ESG Pillars for Business Model Innovation in the Biopharmaceutical Industry
Bhattacharya, Annesha
Bhattacharya, Sonali
AUSTRALASIAN ACCOUNTING BUSINESS AND FINANCE JOURNAL, 2023, 17 (01) : 127 - 150
[27] Impact of genomics on biopharmaceutical industry: rare diseases as disruptive innovation
Ahn, Mark J.
Shaygan, Amir
Weber, Charles
INTERNATIONAL JOURNAL OF INNOVATION SCIENCE, 2019, 11 (02) : 241 - 260
[28] Research on the Transformation and Innovation of Securities Brokerage Business under the Background of Internet Plus
Wu, Jinjiao
2018 INTERNATIONAL CONFERENCE ON COMPUTER, CIVIL ENGINEERING AND MANAGEMENT SCIENCE (ICCEMS 2018), 2018, : 159 - 163
[29] The Influence of Entrepreneurship on the Innovation Path of Cultural Enterprises Under the Background of Digital Transformation
Liu, Siting
Zhou, Yong
Wang, Changlin
Yu, Yufan
FRONTIERS IN PSYCHOLOGY, 2022, 13
[30] Sustainable Innovation in the Biopharmaceutical Industry: An Analysis of the Impact of Policy Configuration
Xiao, Xiao
Cheng, Yue
Zhang, Yuling
SUSTAINABILITY, 2024, 16 (06)

← 1 2 3 4 5 →